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December 6, 2011:2544–9First, a prior study (4) had investigated the role of progressively
worsening glucose control in nondiabetic patients and its effects on
development of chronic kidney disease. With the well-established
role of chronic kidney disease, especially in dysglycemic patients
(5), it would be interesting to know if the investigators made any
attempts to look at the renal functions of the patients and made
any attempts to adjust for the same.
Second, it would also be interesting to know if the investigators
had data on levels of glycosylated hemoglobin (Hb) A1c for the
patients with IFG, and if any attempts were made to correlate the
same with events, as HbA1c has been indicated to better reflect
glycemic status even for IFG patients (6,7).
Third, it would be interesting to know the thoughts of the
investigators regarding the fact that addition of body mass index
only (Fig. 3, Model 3) (1), to the Model 2 (1) multivariable
analysis, changed the outcomes of the study from a statistically
significant one to one that is not.
The role of IFG in de novo cardiovascular events is a fascinating
topic, and we thank Dr. Yeboah and colleagues for shedding light
on interesting facets of the same.
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Reply
We thank Drs. Chatterjee and Maitra for their interest in our
paper regarding impaired fasting glucose and the risk of incident
diabetes mellitus and cardiovascular events in MESA (Multi-
Ethnic Study of Atherosclerosis) (1).
The first question raised was based on the paper by Fox et al. (2)
n glycemic control and development of kidney disease in the
ramingham Heart Study. Individuals with chronic kidney diseaseCKD) have an increased cardiovascular risk, but the relevance ofkidney function in statistical models depends on the cohort under
consideration and the question being asked. Covariates adjusted
for in our models were selected based on evidence of associations
in our univariate analysis and on prior publications. The MESA
cohort by design included relatively healthy individuals with a low
prevalence of CKD. Adding a measure of kidney disease (serum
creatinine, estimated glomerular filtration rate, or cystatin C levels)
did not change either the point estimates or the confidence
intervals of risk estimates reported in our paper.
The authors completely agree with regards to the second question
raised. Indeed, it would have been very interesting if data on
hemoglobin A1c were also provided. Unfortunately even though data
on hemoglobin A1c is available in MESA, it was measured during the
second MESA visit, whereas fasting blood glucose levels used in the
analysis to define participants as having normoglycemia, impaired
fasting glucose, or diabetes mellitus were measured during the
baseline examination (1). We believe that answering the same
question using samples from periods separated by years would yield
inaccurate results and would lead to inaccurate inferences.
Finally, the addition of body mass index to the stepwise Cox
proportional hazard model that included age, sex, and race/ethnicity
attenuated the univariate association between impaired fasting glucose
and incident cardiovascular events in MESA. This is not surprising
given the strong association between body mass index and glucose.
Thus, the apparent association between impaired fasting glucose and
incident cardiovascular events in our univariate analysis could be
explained by a combination of the variance in age, sex, race/ethnicity,
and the body mass index of the subcohort.
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Determinants of Exercise
Intolerance in Heart Failure
With Preserved Ejection Fraction
The article by Haykowsky et al. (1) is a comprehensive examina-
tion of contributors to the reduced exercise capacity universally
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December 6, 2011:2544–9found in elderly patients with heart failure with preserved ejection
fraction (HFpEF). This work is important given the lack of
understanding of the pathophysiology of this disease or proven
therapies. The group is particularly to be commended for their
open-minded approach to potential contributors to the disease.
We do, however, take issue with the method by which their
primary conclusion was reached.
Haykowsky et al. (1) use the Fick equation to derive
arterial-venous oxygen difference (A-VO2 Diff) from measured
O and peak oxygen consumption (VO2). No measurement of
blood oxygen levels or direct measurement of tissue consump-
tion was performed. It is, therefore, a foregone conclusion that
A-VO2 Diff is an independent predictor of VO2, when the latter
as used to calculate the former. Until direct measurement of
eripheral oxygen consumption is performed in HFpEF pa-
ients, we believe the conclusion that this is a primary deter-
inant of exercise intolerance remains an interesting, but
nproven, hypothesis.
We further find the results of decreased A-VO2 Diff in
HFpEF patients confusing, as this is inconsistent with previous
data presented by Kitzman et al. (2), showing a nonstatistically
significant trend of a 10% increase in measured A-VO2 Diff in
FpEF patients versus healthy controls. It also contradicts
ndings in HF with reduced EF patients who have a significant
ncrease in A-VO2 Diff compared to healthy control subjects,
not only at peak exercise, but also at rest and submaximal
exercise (3). The discrepancy might be due to calculation rather
than measurement of A-VO2 Diff. Further study to validate the
use of calculated A-VO2 Diff versus direct measurement seems
imperative.
There is no question that the exercise intolerance in HFpEF
is complex and multifactorial. Our group and others have shown
that inadequate contractile reserve contributes to this physiol-
ogy (4), a conclusion supported by failure of the HFpEF
patients in the Haykowsky study (1) to increase EF or decrease
end-systolic volume with exercise. Failure to increase CO
appropriately with exercise clearly contributes, and mounting
data suggest inadequate vasodilator reserve also plays a role.
However, until peripheral oxygen consumption is directly mea-
sured, concluding that reduced A-VO2 Diff contributes to
xercise intolerance remains an assumption based on mathe-
atical derivation.
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Reply
We thank Drs. Halbe and Sweitzer for their interest in our
paper (1). We appreciate the commendations from Drs. Halbe
and Sweitzer, who are knowledgeable investigators of heart
failure with preserved ejection fraction (HFpEF). We agree
with their premise that understanding the pathophysiology of
reduced exercise capacity requires measurement of key variables
during peak exercise, which can be challenging and has not been
commonly done.
By the Fick principle for oxygen, reduced exercise capacity
measured objectively as peak oxygen consumption (VO2) must be
ue to reduced peak cardiac output, reduced peak arteriovenous
xygen difference (A-VO2 Diff), or a combination. Given this, and
he fact that A-VO2 Diff is known to be an important contributor
o exercise capacity in healthy persons and those with heart failure
ith reduced ejection fraction (HFrEF), our findings regarding its
ole in HFpEF are not surprising. We also agree that the
ontributors to reduced exercise capacity in HFpEF, as in HFrEF,
re “multifactorial and complex.” Our primary conclusion, that
oth cardiac output and A-VO2 Diff are reduced at peak and
ontribute to reduced exercise capacity, is strongly consistent with
his concept.
The Fick technique is a well-accepted method for calculating either
-VO2 Diff or cardiac output when the other and VO2 are known by
irect measurement (2). It is viewed as the gold standard for cardiac
utput assessment, is routinely used in cardiac catheterization labora-
ories for critical patient care decisions (2), has been used in many
rior studies aimed at understanding mechanisms of reduced exercise
apacity including those cited by Halbe and Sweitzer (3,4), and is
qually valid for calculation of A-VO2 Diff.
We agree that direct measurement of A-VO2 Diff would be
esirable, but it involves simultaneous catheterization of sys-
emic and pulmonary arteries during upright, maximal exercise,
hich involves significant risks, particularly for healthy subjects.
valuable feature of our study was the inclusion of a healthy
ontrol group for comparison to our HFpEF patients. Impor-
antly, the use of identical methods in both groups helped
nsure the validity of our intergroup comparisons on which our
onclusions were based.
We agree that use of a Fick-calculated variable could potentially
ias the regression analyses to determine the factors most strongly
elated to reduced peak VO2. However, this statistical method has
een used in previously published studies including those cited by
albe and Sweitzer (3,4). Furthermore, we took several steps to
inimize bias. First, instead of examining peak variables, we
xamined the relationships of reserve variables (peak – rest) with
eak VO2; this significantly reduces collinearity bias. Second, we
used a prediction variable (peak VO2) that we’ve shown has high
reproducibility (5). The size of the bias is positively associated with
the ratio of the variance of the measurement error in observing
